Personal information

Activities

Employment (1)

First Pavlov State Medical University of St. Petersburg: Saint Petersburg, Saint Petersburg, RU

2020-09-01 to present | Head (Chemotherapy and bone marrow transplantation)
Employment
Source: Self-asserted source
Kirill Lepik

Professional activities (4)

European Society for Blood and Marrow Transplantation: London, London, GB

Membership
Source: Self-asserted source
Kirill Lepik

European Hematology Association: The Hague, NL

Membership
Source: Self-asserted source
Kirill Lepik

American Society of Hematology: Washington, DC, US

Membership
Source: Self-asserted source
Kirill Lepik

American Society of Gene Therapy and Cell Therapy: Milwaukee, Wisconsin, US

Membership
Source: Self-asserted source
Kirill Lepik

Funding (1)

Fundamentals of editing the genome of hematopoietic stem cells and T lymphocytes with TALEN and CRISPR / Cas9 nucleases.

2019-01-01 to 2019-12-31 | Grant
Russian Foundation for Basic Research (Moscow, RU)
GRANT_NUMBER:

19-29-04025

Source: Self-asserted source
Kirill Lepik
grade
Preferred source (of 2)‎

Works (50 of 55)

Items per page:
Page 1 of 2

Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)

Regulatory Research and Medicine Evaluation
2025-02-03 | Journal article
Contributors: M. L. Vasyutina; K. V. Lepik; M. S. Istomina; K. A. Levchuk; A. V. Petukhov; E. V. Shchelina; A. E. Ershova; O. N. Demidov; Ya. G. Toropova
Source: check_circle
Crossref

Development of a preclinical model of myeloid tumors with high immune checkpoints expression

Oncohematology
2024-12-10 | Journal article
Contributors: D. A. Senichkina; A. I. Shakirova; O. S. Epifanovskaya; I. N. Gaponenko; T. A. Pyatiizbyantsev; E. V. Belotserkovskaya; A. B. Malyshecheva; K. V. Lepik; I. S. Moiseev
Source: check_circle
Crossref

Therapeutic vaccines for follicular lymphoma: a systematic review protocol

2023-08-23 | Preprint
Contributors: Pavel Zhelnov; Andrei Suponin; Artem Potanin; Aleksandr Lomazov; Kseniia Vladimirova; Kirill Lepik; Albert Muslimov
Source: check_circle
Crossref

Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma

The Scientific Notes of the Pavlov University
2022-07-04 | Journal article
Contributors: A. M. Chekalov; M. O. Popova; I. V. Tsygankov; Yu. A. Rogacheva; N. P. Volkov; K. V. Lepik; M. V. Demchenkova; T. V. Schneider; Yu. V. Kopeikina; N. V. Medvedeva et al.
Source: check_circle
Crossref

Layer-by-Layer-Assembled Capsule Size Affects the Efficiency of Packaging and Delivery of Different Genetic Cargo

Particle and Particle Systems Characterization
2021 | Journal article
EID:

2-s2.0-85097296382

Part of ISSN: 15214117 09340866
Contributors: Tarakanchikova, Y.V.; Muslimov, A.R.; Zyuzin, M.V.; Nazarenko, I.; Timin, A.S.; Sukhorukov, G.B.; Lepik, K.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier
grade
Preferred source (of 2)‎

Nivolumab-based immunotherapy in relapsed/refractory b-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical hodgkin lymphoma

Cellular Therapy and Transplantation
2021 | Journal article
EID:

2-s2.0-85108178206

Part of ISSN: 18668836 1867416X
Contributors: Smykova, O.G.; Lepik, K.V.; Mikhailova, N.B.; Kondakova, E.V.; Borzenkova, E.S.; Lepik, E.E.; Zalyalov, Y.R.; Stelmakh, L.V.; Baykov, V.V.; Moiseev, I.S. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

<i>N</i>-[4-(<i>N,N,N</i>-Trimethylammonium)Benzyl]Chitosan Chloride as a Gene Carrier: The Influence of Polyplex Composition and Cell Type.

Materials (Basel, Switzerland)
2021-05 | Journal article
Contributors: Raik SV; Mashel TV; Muslimov AR; Epifanovskaya OS; Trofimov MA; Poshina DN; Lepik KV; Skorik YA
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Boosting transfection efficiency: A systematic study using layer-by-layer based gene delivery platform.

Materials science & engineering. C, Materials for biological applications
2021-05 | Journal article
Contributors: Tarakanchikova YV; Linnik DS; Mashel T; Muslimov AR; Pavlov S; Lepik KV; Zyuzin MV; Sukhorukov GB; Timin AS
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Layer-by-Layer technique as a versatile tool for gene delivery applications.

Expert opinion on drug delivery
2021-02 | Journal article
Contributors: Linnik DS; Tarakanchikova YV; Zyuzin MV; Lepik KV; Aerts JL; Sukhorukov G; Timin AS
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma.

Annals of hematology
2021-02 | Journal article
Contributors: Fedorova LV; Lepik KV; Mikhailova NB; Kondakova EV; Zalyalov YR; Baykov VV; Babenko EV; Kozlov AV; Moiseev IS; Afanasyev BV
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Achievements and challenges of evidence-based medicine in hematopoietic stem cell transplantation: An analysis of single-center and multicenter trials,Достижения и проблемы доказательной медицины при трансплантации гемопоэтических стволовых клеток: анализ результатов одноцентровых и многоцентровых исследований

Klinicheskaya Onkogematologiya/Clinical Oncohematology
2020 | Journal article
EID:

2-s2.0-85097466400

Part of ISSN: 25002139 19976933
Contributors: Afanasyev, B.V.; Moiseev, I.S.; Volkov, N.G.; Lepik, K.V.; Mikhailova, N.B.; Bondarenko, S.N.; Zubarovskaya, L.S.; Morozova, E.V.; Paina, O.V.; Kozhokar, P.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Long-term outcomes of nivolumab therapy in patients with relapsed/refractory classic hodgkin's lymphoma after high-dose chemotherapy with autologous hematopoietic stem cell transplantation in real clinical practice,Отдаленные результаты терапии ниволумабом у пациентов с рецидивами и рефрактерным течением классической лимфомы Ходжкина после высокодозной химиотерапии с трансплантацией аутологичных гемопоэтических стволовых клеток в реальной клинической практике

Klinicheskaya Onkogematologiya/Clinical Oncohematology
2020 | Journal article
EID:

2-s2.0-85097293333

Part of ISSN: 25002139 19976933
Contributors: Lepik, K.V.; Volkov, N.P.; Mikhailova, N.B.; Kondakova, E.V.; Tsvetkova, L.A.; Zalyalov, Yu.R.; Lepik, E.E.; Fedorova, L.V.; Beinarovich, A.V.; Demchenkova, M.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Modern immunotherapy methods in pediatric patients with cancer

Pediatriya - Zhurnal im G.N. Speranskogo
2020 | Journal article
EID:

2-s2.0-85089665476

Part of ISSN: 19902182 0031403X
Contributors: Kazantsev, I.V.; Lepik, K.V.; Moiseev, I.S.; Zubarovskaya, L.S.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier
grade
Preferred source (of 2)‎

The role of allogeneic hematopoietic stem cell transplantation in children with hodgkin’s lymphoma

Pediatriya - Zhurnal im G.N. Speranskogo
2020 | Journal article
EID:

2-s2.0-85089003943

Part of ISSN: 19902182 0031403X
Contributors: Kozlov, A.V.; Yukhta, T.V.; Tolkunova, P.S.; Gevorgyan, A.G.; Kazantsev, I.V.; Lepik, K.V.; Beinarovich, A.V.; Markova, I.V.; Botina, A.V.; Baykov, V.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier
grade
Preferred source (of 2)‎

The use of checkpoint inhibitors in children with non-hodgkin lymphomas

Pediatric Hematology/Oncology and Immunopathology
2020 | Journal article
EID:

2-s2.0-85088936660

Part of ISSN: 24149314 17261708
Contributors: Kozlov, A.V.; Kazantsev, I.V.; Yukhta, T.V.; Tolkunova, P.S.; Gevorgyan, A.G.; Lepik, K.V.; Zvyagintseva, D.A.; Golenkova, M.S.; Shvetsov, A.N.; Smykova, O.G. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier
grade
Preferred source (of 2)‎

Treatment options for T-cell lymphomas: A single-center study

Cellular Therapy and Transplantation
2020 | Journal article
EID:

2-s2.0-85086454088

Part of ISSN: 18668836 1867416X
Contributors: Lepik, E.E.; Kozlov, A.V.; Borzenkova, E.S.; Zalyalov, Y.R.; Lepik, K.V.; Kondakova, E.V.; Baykov, V.V.; Moiseev, I.S.; Schneider, T.V.; Mikhaylova, N.B. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

A highly efficient and safe gene delivery platform based on polyelectrolyte core-shell nanoparticles for hard-to-transfect clinically relevant cell types.

Journal of materials chemistry. B
2020-10 | Journal article
Contributors: Tarakanchikova Y; Muslimov A; Sergeev I; Lepik K; Yolshin N; Goncharenko A; Vasilyev K; Eliseev I; Bukatin A; Sergeev V et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma.

HemaSphere
2020-09 | Journal article
Contributors: Lepik KV; Fedorova LV; Kondakova EV; Zalyalov YR; Babenko EV; Lepik EE; Kotselyabina PV; Beynarovich AV; Popova MO; Volkov NP et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central

DDAO Controlled Synthesis of Organo-Modified Silica Nanoparticles with Encapsulated Fluorescent Boron Dipyrrins and Study of Their Uptake by Cancerous Cells.

Molecules (Basel, Switzerland)
2020-08 | Journal article
Contributors: Goncharenko AA; Tarasyuk IA; Marfin YS; Grzhegorzhevskii KV; Muslimov AR; Bondarenko AB; Lebedev MD; Kuz'min IA; Vashurin AS; Lepik KV et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods.

Biomaterials
2020-08 | Journal article
Contributors: Mashel TV; Tarakanchikova YV; Muslimov AR; Zyuzin MV; Timin AS; Lepik KV; Fehse B
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure.

HemaSphere
2020-06 | Journal article
Contributors: Lepik KV; Mikhailova NB; Kondakova EV; Zalyalov YR; Fedorova LV; Tsvetkova LA; Kotselyabina PV; Borzenkova ES; Babenko EV; Popova MO et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome.

Leukemia research reports
2020-06 | Journal article
Contributors: Tcvetkov N; Gusak A; Morozova E; Moiseev I; Baykov V; Barabanshikova M; Lepik K; Bakin E; Vlasova J; Osipova A et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Allogeneic hematopoietic stem cell transplantation for relapsed and refractory chronic lymphocytic leukemia: Single-center experience

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85079684588

Part of ISSN: 18668836 1867416X
Contributors: Kalashnikova, O.B.; Ivanova, M.O.; Shmidt, D.I.; Lepik, K.V.; Borzenkova, E.S.; Nemykin, V.N.; Kondakova, E.V.; Mikhaylova, N.B.; Darskaya, E.I.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Assessment of cytokine levels in the patients with relapsed/refractory hodgkin’s lyphoma during nivolumab therapy

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85076740003

Part of ISSN: 18668836 1867416X
Contributors: Chekalov, A.M.; Lepik, K.V.; Yolshin, N.D.; Muslimov, A.R.; Mikhailova, N.B.; Kondakova, E.V.; Tsvetkova, L.A.; Zalyalov, Y.R.; Borzenkova, E.S.; Moiseev, I.S. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Brentuximab vedotin in the treatment of children and adolescents with refractory and relapsed Hodgkin's lymphoma

Pediatric Hematology/Oncology and Immunopathology
2019 | Journal article
EID:

2-s2.0-85068454939

Part of ISSN: 24149314 17261708
Contributors: Kozlov, A.V.; Kazantzev, I.V.; Iukhta, T.V.; Tolkunova, P.S.; Gevorgian, A.G.; Lepik, K.V.; Borzenkova, E.S.; Zaljalov, Y.R.; Botina, A.V.; Baikov, V.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier
grade
Preferred source (of 2)‎

Efficacy and safety of nivolumab combinations in patients with relapsed or refractory classical hodgkin lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85081267960

Part of ISSN: 18668836 1867416X
Contributors: Kotselyabina, P.V.; Mikhailova, N.B.; Lepik, K.V.; Kondakova, E.V.; Kozlov, A.V.; Zalyalov, Y.R.; Popova, M.O.; Borzenkova, E.S.; Moiseev, I.S.; Baykov, V.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Frontline R-EPOCH in HIV-infected patients with non-hodgkin’s lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85078559053

Part of ISSN: 18668836 1867416X
Contributors: Tsygankov, I.V.; Popova, M.O.; Rogacheva, Y.A.; Lepik, K.V.; Zalyalov, Y.R.; Stelmakh, L.V.; Moiseev, I.S.; Bondarenko, S.N.; Mikhaylova, N.B.; Baykov, V.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Highlights of the 24<sup>th</sup> European hematology association congress, Amsterdam 2019

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85074974070

Part of ISSN: 18668836 1867416X
Contributors: Fedorova, L.V.; Lepik, K.V.; Popova, M.O.; Vlasova, Y.Y.; Kudyasheva, O.V.; Rogacheva, Y.A.; Lepik, E.E.; Porunova, V.V.; Osipova, A.A.; Zalyalov, Y.R. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Immune checkpoint inhibitor salvage therapy in patient with refractory primary central nervous system lymphoma

Voprosy Onkologii
2019 | Journal article
EID:

2-s2.0-85082128646

Part of ISSN: 05073758
Contributors: Lepik, K.V.; Polushin, A.Yu.; Kondakova, E.V.; Yakimovich, K.P.; TSygankov, I.V.; Gavrilenko, A.N.; Zalyalov, Yu.R.; Mikhailova, N.B.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Immunochemotherapy in relapsed or refractory B-cell non-hodgkin lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85079696214

Part of ISSN: 18668836 1867416X
Contributors: Smykova, O.G.; Lepik, K.V.; Kondakova, E.V.; Zalyalov, Y.R.; Stelmakh, L.V.; Darskaya, E.I.; Mikhailova, N.B.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Invasive fungal diseases before and after allogeneic hematopoietic stem cell transplantation in children and adults with relapsed/refractory hodgkin’s lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85079676783

Part of ISSN: 18668836 1867416X
Contributors: Rogacheva, Y.A.; Popova, M.O.; Volkova, A.G.; Markova, I.V.; Shvetsov, A.N.; Nikolaev, I.Y.; Goloshchapov, O.V.; Ignatieva, S.M.; Bogomolova, T.S.; Kozlov, A.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Nivolumab in pediatric hodgkin's lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85078876544

Part of ISSN: 18668836 1867416X
Contributors: Kozlov, A.V.; Kazantzev, I.V.; Iukhta, T.V.; Tolkunova, P.S.; Zvyagintseva, D.A.; Gevorgian, A.G.; Malorodov, A.V.; Lepik, K.V.; Zalyalov, Y.R.; Shvetsov, A.N. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Polymeric micro-and nano-carriers as a universal platform for delivery of biologically active substances to therapeutically cell populations

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85079647131

Part of ISSN: 18668836 1867416X
Contributors: Muslimov, A.R.; Mashel, T.V.; Peltek, O.O.; Trofimov, M.A.; Sergeev, I.S.; Tarakanchikova, Y.V.; Goncharenko, A.A.; Lepik, K.V.; Zyuzin, M.V.; Timin, A.S.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Quality of life and clinical response to brentuximab vedotin in patients with relapsed/refractory hodgkin lymphoma (RR HL) in the real-world setting

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85081217101

Part of ISSN: 18668836 1867416X
Contributors: Ionova, T.I.; Afanasyev, B.V.; Amdiev, A.A.; Andrievskikh, M.I.; Baryakh, E.A.; Vasiliev, E.V.; Volkov, M.V.; Volodicheva, E.M.; Ivanov, V.V.; Kaverina, O.V. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical hodgkin lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85076725694

Part of ISSN: 18668836 1867416X
Contributors: Beynarovich, A.V.; Lepik, K.V.; Mikhailova, N.B.; Kondakova, E.V.; Zalyalov, Y.R.; Borzenkova, E.S.; Babenko, E.V.; Darskaya, E.I.; Moiseev, I.S.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Treatment of patients with central nervous system lymphoma

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85078561195

Part of ISSN: 18668836 1867416X
Contributors: Shmidt, D.I.; Gavrilenko, A.N.; Polushin, A.Y.; Kondakova, E.V.; Lepik, K.V.; Medvedeva, N.V.; Klimovich, A.V.; Zalyalov, Y.R.; Mikhailova, N.B.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Treatment of T-cell lymphomas: First pavlov state medical university of saint petersburg experience

Cellular Therapy and Transplantation
2019 | Journal article
EID:

2-s2.0-85076794145

Part of ISSN: 18668836 1867416X
Contributors: Lepik, E.E.; Kozlov, A.V.; Borzenkova, E.S.; Zalyalov, Y.R.; Lepik, K.V.; Kondakova, E.V.; Baykov, V.V.; Moiseev, I.S.; Schneider, T.V.; Mikhaylova, N.B. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers.

ACS applied materials & interfaces
2019-03 | Journal article
Contributors: Timin AS; Peltek OO; Zyuzin MV; Muslimov AR; Karpov TE; Epifanovskaya OS; Shakirova AI; Zhukov MV; Tarakanchikova YV; Lepik KV et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.

Leukemia & lymphoma
2019-02 | Journal article
Contributors: Lepik KV; Mikhailova NB; Moiseev IS; Kondakova EV; Tsvetkova LA; Zalyalov YR; Borzenkova ES; Babenko EV; Baykov VV; Markova IV et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience,Эффективность и безопасность ниволумаба в лечении рецидивирующей и рефрактерной классической лимфомы Ходжкина: опыт ПСПбГМУ им. акад. И.П. Павлова

Oncogematologiya
2018 | Journal article
EID:

2-s2.0-85065058140

Part of ISSN: 24134023 18188346
Contributors: Lepik, K.V.; Mikhailova, N.B.; Kondakova, E.V.; Tsvetkova, L.A.; Zalyalov, Y.R.; Borzenkova, E.S.; Moiseev, I.S.; Baykov, V.V.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Immune checkpoint inhibitors in the treatment of lymphomas,Ингибиторы иммунных контрольных точек в терапии лимфом

Klinicheskaya Onkogematologiya/Clinical Oncohematology
2018 | Journal article
EID:

2-s2.0-85078946616

Part of ISSN: 25002139 19976933
Contributors: Lepik, K.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Safety and efficacy of nivolumab applied at different dosage in the patients with relapsing hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation

Cellular Therapy and Transplantation
2018 | Journal article
EID:

2-s2.0-85055346267

Part of ISSN: 18668836 1867416X
Contributors: Lepik, K.V.; Kozlov, A.V.; Borzenkova, E.S.; Popova, M.O.; Moiseev, I.S.; Darskaya, E.I.; Gevorgyan, A.G.; Tsvetkova, L.A.; Bondarenko, S.N.; Alyanskiy, A.L. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Autologous hematopoietic cell transplantation for HIV-related lymphoma: Results of a single center (CIC725) matched case-control study

Cellular Therapy and Transplantation
2017 | Journal article
EID:

2-s2.0-85045661443

Part of ISSN: 18668836 1867416X
Contributors: Popova, M.O.; Rogacheva, Y.A.; Nekrasova, A.V.; Tsygankov, I.V.; Basahel, A.; Lepik, K.V.; Pirogova, O.V.; Darskaya, E.I.; Stelmakh, L.V.; Zalyalov, Y.R. et al.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Clinical implementation of genome editing for correction of human diseases

Cellular Therapy and Transplantation
2017 | Journal article
EID:

2-s2.0-85021639853

Part of ISSN: 18668836 1867416X
Contributors: Popova, M.O.; Lepik, K.V.; Sergeev, V.S.; Shakirova, A.I.; Potter, A.Y.; Muslimov, A.R.; Barkhatov, I.M.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Gene-cell therapy of HIV and hematological malignances based on hematopoietic stem cell transplantation and site-specific genome editing

Jurnal Infektologii
2017 | Journal article
EID:

2-s2.0-85018369758

Part of ISSN: 24999865 20726732
Contributors: Popova, M.O.; Sergeev, V.S.; Lepik, K.V.; Shakirova, A.I.; Potter, A.Y.; Barhatov, I.M.; Fehse, B.; Afanasyev, B.V.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

Intracellular Breakable and Ultrasound-Responsive Hybrid Microsized Containers for Selective Drug Release into Cancerous Cells

Particle and Particle Systems Characterization
2017 | Journal article
EID:

2-s2.0-85014472683

Part of ISSN: 15214117 09340866
Contributors: Timin, A.S.; Muslimov, A.R.; Lepik, K.V.; Okilova, M.V.; Tcvetkov, N.Y.; Shakirova, A.I.; Afanasyev, B.V.; Gorin, D.A.; Sukhorukov, G.B.
Source: Self-asserted source
Kirill Lepik via Scopus - Elsevier

A comparison study between electrospun polycaprolactone and piezoelectric poly(3-hydroxybutyrate-co-3-hydroxyvalerate) scaffolds for bone tissue engineering.

Colloids and surfaces. B, Biointerfaces
2017-09 | Journal article
Contributors: Gorodzha SN; Muslimov AR; Syromotina DS; Timin AS; Tcvetkov NY; Lepik KV; Petrova AV; Surmeneva MA; Gorin DA; Sukhorukov GB et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficient gene editing via non-viral delivery of CRISPR-Cas9 system using polymeric and hybrid microcarriers.

Nanomedicine : nanotechnology, biology, and medicine
2017-09 | Journal article
Contributors: Timin AS; Muslimov AR; Lepik KV; Epifanovskaya OS; Shakirova AI; Mock U; Riecken K; Okilova MV; Sergeev VS; Afanasyev BV et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Mesenchymal Stem Cells Engineering: Microcapsules-Assisted Gene Transfection and Magnetic Cell Separation.

ACS biomaterials science & engineering
2017-09 | Journal article
Contributors: Muslimov AR; Timin AS; Petrova AV; Epifanovskaya OS; Shakirova AI; Lepik KV; Gorshkov A; Il'inskaja EV; Vasin AV; Afanasyev BV et al.
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎

Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.

Scientific reports
2017-03 | Journal article
Contributors: Timin AS; Muslimov AR; Petrova AV; Lepik KV; Okilova MV; Vasin AV; Afanasyev BV; Sukhorukov GB
Source: Self-asserted source
Kirill Lepik via Europe PubMed Central
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2